Human–mouse comparison of the multistage nature of radiation carcinogenesis in a mathematical model
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34987 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Tatsuhiko Imaoka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Effects Research, Institute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, Japan. Hauptthemen laut MEDLINE: Neoplasms, Radiation-Induced, Carcinogenesis. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Mouse models are vital for assessing risk from environmental carcinogens, including ionizing radiation, yet the interspecies difference in the dose response precludes direct application of experimental evidence to humans. Herein, we take a mathematical approach to delineate the mechanism underlying the human–mouse difference in radiation‐related cancer risk. We used a multistage carcinogenesis model assuming a mutational action of radiation to analyze previous data on cancer mortality in the Japanese atomic bomb survivors and in lifespan mouse experiments. Theoretically, the model predicted that exposure will chronologically shift the age‐related increase in cancer risk forward by a period corresponding to the time in which the spontaneous mutational process generates the same mutational burden as that the exposure generates. This model appropriately fitted both human and mouse data and suggested a linear dose response for the time shift. The effect per dose decreased with increasing age at exposure similarly between humans and mice on a per‐lifespan basis (0.72‐ and 0.71‐fold, respectively, for every tenth lifetime). The time shift per dose was larger by two orders of magnitude in humans (7.8 and 0.046 years per Gy for humans and mice, respectively, when exposed at ~35% of their lifetime). The difference was mostly explained by the two orders of magnitude difference in spontaneous somatic mutation rates between the species plus the species‐independent radiation‐induced mutation rate. Thus, the findings delineate the mechanism underlying the interspecies difference in radiation‐associated cancer mortality and may lead to the use of experimental evidence for risk prediction in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Effects Research, Institute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
- Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
- Department of Radiobiology, Institute for Environmental Sciences, Rokkasho, Japan.
- Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry, Chiba, Japan.
- Department of Radiation Regulatory Science Research, Institute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.
ORCID-Profile: Tatsuhiko Imaoka, Shizuko Kakinuma
Zitieren
APA
Imaoka, T., Tanaka, S., Tomita, M., Doi, K., Sasatani, M., Suzuki, K., Yamada, Y., Kakinuma, S., & Kai, M. (2024). Human–mouse comparison of the multistage nature of radiation carcinogenesis in a mathematical model. International Journal of Cancer. https://doi.org/10.1002/ijc.34987
Vancouver
Imaoka T, Tanaka S, Tomita M, Doi K, Sasatani M, Suzuki K, et al. Human–mouse comparison of the multistage nature of radiation carcinogenesis in a mathematical model. International Journal of Cancer. 2024. doi:10.1002/ijc.34987
BibTeX
@article{Imaoka2024,
author = {Imaoka, Tatsuhiko and Tanaka, Satoshi and Tomita, Masanori and Doi, Kazutaka and Sasatani, Megumi and Suzuki, Keiji and Yamada, Yutaka and Kakinuma, Shizuko and Kai, Michiaki},
title = {Human–mouse comparison of the multistage nature of radiation carcinogenesis in a mathematical model},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34987}
}
EUVIMED